Approved Symbol |
Approved Name |
Location |
Source |
TAAR5 |
trace amine associated receptor 5 |
6q23.2 |
Mapped by significant region |
GRIN3A |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A |
9q |
Mapped by significant region |
TAAR6 |
trace amine associated receptor 6 |
6q23.1 |
Mapped by significant region |
CCKAR |
cholecystokinin A receptor |
4 |
Mapped by CNV |
TAAR8 |
trace amine associated receptor 8 |
6q23.2 |
Mapped by significant region |
PRLR |
prolactin receptor |
5p14-p13 |
Mapped by significant region |
TAAR9 |
trace amine associated receptor 9 (gene/pseudogene) |
6q23.1 |
Mapped by significant region |
GRIA4 |
glutamate receptor, ionotrophic, AMPA 4 |
11q22 |
Mapped by significant region |
GPR83 |
G protein-coupled receptor 83 |
11q21 |
Mapped by significant region |
GABRB3 |
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
15q11.2-q12 |
Mapped by CNV; Mapped by significant region |
GABRG3 |
gamma-aminobutyric acid (GABA) A receptor, gamma 3 |
15q11-q13 |
Mapped by CNV; Mapped by significant region |
P2RX6 |
purinergic receptor P2X, ligand-gated ion channel, 6 |
22q11.21 |
Mapped by CNV |
GHR |
growth hormone receptor |
5p14-p12 |
Mapped by CNV; Mapped by significant region |
S1PR3 |
sphingosine-1-phosphate receptor 3 |
9q22.1-q22.2 |
Mapped by significant region |
GRM6 |
glutamate receptor, metabotropic 6 |
5q35 |
Mapped by CNV |
TAAR2 |
trace amine associated receptor 2 |
6q24 |
Mapped by significant region |
TAAR1 |
trace amine associated receptor 1 |
6q23.1 |
Mapped by significant region |
GABRA5 |
gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
15q11-q13 |
Mapped by CNV; Mapped by significant region |
ADORA2A |
adenosine A2a receptor |
22q11.23 |
Mapped by CNV |
MC2R |
melanocortin 2 receptor (adrenocorticotropic hormone) |
18p11.2 |
Mapped by CNV |
F2RL2 |
coagulation factor II (thrombin) receptor-like 2 |
5q13 |
Mapped by PBA pathway |
GNRHR |
gonadotropin-releasing hormone receptor |
4q21.2 |
Mapped by significant region |
SCTR |
secretin receptor |
2q14.1 |
Mapped by LD-proxy |
EDNRA |
endothelin receptor type A |
4 |
Mapped by PBA pathway |
MC5R |
melanocortin 5 receptor |
18p11.2 |
Mapped by CNV |
LTB4R |
leukotriene B4 receptor |
14q11.2-q12 |
Mapped by significant region |
LTB4R2 |
leukotriene B4 receptor 2 |
14q11.2-q12 |
Mapped by significant region |
APLNR |
apelin receptor |
11q12.1 |
Mapped by significant region |
TACR3 |
tachykinin receptor 3 |
4q25 |
Mapped by CNV |
CHRNB4 |
cholinergic receptor, nicotinic, beta 4 |
15q24 |
Mapped by LD-proxy |
C3AR1 |
complement component 3a receptor 1 |
12p13.31 |
Mapped by PBA pathway |
LPAR1 |
lysophosphatidic acid receptor 1 |
9q |
Mapped by significant region |
BDKRB2 |
bradykinin receptor B2 |
14q32.1-q32.2 |
Mapped by PBA pathway |
HRH4 |
histamine receptor H4 |
18q11.2 |
Mapped by significant region |
CCKBR |
cholecystokinin B receptor |
11p15.4 |
Mapped by CNV; Mapped by PBA pathway |
CHRM3 |
cholinergic receptor, muscarinic 3 |
1q41-q44 |
Mapped by CNV; Mapped by PBA pathway |
CHRM5 |
cholinergic receptor, muscarinic 5 |
15q26 |
Mapped by CNV; Mapped by PBA pathway |
CHRM1 |
cholinergic receptor, muscarinic 1 |
11q12-q13 |
Mapped by PBA pathway; Mapped by significant region |
PTGER4 |
prostaglandin E receptor 4 (subtype EP4) |
5p13.1 |
Mapped by significant region |
NTSR2 |
neurotensin receptor 2 |
2p25.1 |
Mapped by significant region |
CHRNA5 |
cholinergic receptor, nicotinic, alpha 5 |
15q24 |
Mapped by LD-proxy |
MC4R |
melanocortin 4 receptor |
18q22 |
Mapped by significant region |
MC1R |
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) |
16q24.3 |
Mapped by significant region |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
17p13.3 |
Mapped by PBA pathway |
GABBR2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
9q22.1-q22.3 |
Mapped by significant region |
CTSG |
cathepsin G |
14q12 |
Mapped by significant region |
P2RY2 |
purinergic receptor P2Y, G-protein coupled, 2 |
11q13.5-q14.1 |
Mapped by significant region |
P2RX3 |
purinergic receptor P2X, ligand-gated ion channel, 3 |
11q12 |
Mapped by significant region |
P2RY6 |
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
11q13.5 |
Mapped by significant region |